CORRECTING and REPLACING PAVmed to Hold Business Update Conference Call on August 12, 2021 Aug 02, 2021 9:30am EDT
Stanley Lapidus, Founder and Former Chairman & CEO of Exact Sciences, Joins PAVmed Subsidiary Lucid Diagnostics as Vice Chairman of its Board of Directors Jul 28, 2021 9:30am EDT
PAVmed Subsidiary Lucid Diagnostics Launches Strategic Partnership with Direct-to-Consumer Telemedicine Company UpScriptHealth Jul 22, 2021 9:30am EDT
Tim Baxter, Former CEO of Samsung Electronics North America and Global Technology Industry Leader, Joins PAVmed Board of Directors Jun 14, 2021 9:30am EDT
PAVmed Subsidiary Lucid Diagnostics Completes European CE Mark Certification of its EsoGuard Esophageal DNA Test Jun 10, 2021 9:30am EDT
PAVmed Subsidiary Lucid Diagnostics Receives CE Mark Certification for its EsoCheck® Esophageal Cell Collection Device May 26, 2021 9:30am EDT
PAVmed Receives European CE Mark Certification for its CarpX® Minimally Invasive Carpal Tunnel Device May 25, 2021 9:30am EDT
Data Presented at Digestive Disease Week 2021 Support Clinical Utility of PAVmed Subsidiary Lucid Diagnostics’ EsoCheck and EsoGuard Technologies May 24, 2021 9:30am EDT